Companies founded on innovation and strong science
RougeTx
RougeTx is a spin-off from Leiden University Medical Center (LUMC) and is developing first-inclass small-molecule therapies to restore vascular stability in diseases driven by pericyte dysfunction.
RougeTx
Sector:
Biotechnology
Country:
Netherlands
Year of first investment:
2026
Status:
Active
Website:
rougetx.com
Other investments
